Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected with Toxoplasma gondii.

Jones LA, Roberts F, Nickdel MB, Brombacher F, McKenzie AN, Henriquez FL, Alexander J, Roberts CW.

Eur J Immunol. 2010 Feb;40(2):426-36. doi: 10.1002/eji.200939705.

2.
3.
5.

IL-33 signaling is essential to attenuate viral-induced encephalitis development by downregulating iNOS expression in the central nervous system.

Franca RF, Costa RS, Silva JR, Peres RS, Mendonça LR, Colón DF, Alves-Filho JC, Cunha FQ.

J Neuroinflammation. 2016 Jun 22;13(1):159. doi: 10.1186/s12974-016-0628-1.

6.

Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.

Schlüter D, Kwok LY, Lütjen S, Soltek S, Hoffmann S, Körner H, Deckert M.

J Immunol. 2003 Jun 15;170(12):6172-82.

9.

The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.

Rostan O, Gangneux JP, Piquet-Pellorce C, Manuel C, McKenzie AN, Guiguen C, Samson M, Robert-Gangneux F.

MBio. 2013 Sep 17;4(5):e00383-13. doi: 10.1128/mBio.00383-13.

10.
12.
13.

Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction.

Brint EK, Fitzgerald KA, Smith P, Coyle AJ, Gutierrez-Ramos JC, Fallon PG, O'Neill LA.

J Biol Chem. 2002 Dec 20;277(51):49205-11. Epub 2002 Oct 3.

14.

Temporal differences in the expression of mRNA for IL-10 and IFN-gamma in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii.

Burke JM, Roberts CW, Hunter CA, Murray M, Alexander J.

Parasite Immunol. 1994 Jun;16(6):305-14.

PMID:
7970867
15.

Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control.

Vossenkämper A, Struck D, Alvarado-Esquivel C, Went T, Takeda K, Akira S, Pfeffer K, Alber G, Lochner M, Förster I, Liesenfeld O.

Eur J Immunol. 2004 Nov;34(11):3197-207.

16.

IL-33/ST2 involves the immunopathology of ocular toxoplasmosis in murine model.

Tong X, Lu F.

Parasitol Res. 2015 May;114(5):1897-905. doi: 10.1007/s00436-015-4377-3. Epub 2015 Feb 20.

PMID:
25693767
17.

MyD88 is crucial for the development of a protective CNS immune response to Toxoplasma gondii infection.

Torres M, Guiton R, Lacroix-Lamandé S, Ryffel B, Leman S, Dimier-Poisson I.

J Neuroinflammation. 2013 Feb 1;10:19. doi: 10.1186/1742-2094-10-19.

18.

TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection.

Mun HS, Aosai F, Norose K, Chen M, Piao LX, Takeuchi O, Akira S, Ishikura H, Yano A.

Int Immunol. 2003 Sep;15(9):1081-7.

PMID:
12917260
19.

Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.

Cai G, Radzanowski T, Villegas EN, Kastelein R, Hunter CA.

J Immunol. 2000 Sep 1;165(5):2619-27.

20.

In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.

Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kühn R, Müller W, Trinchieri G, Sher A.

J Immunol. 1996 Jul 15;157(2):798-805.

PMID:
8752931

Supplemental Content

Support Center